Navigation path

Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use

RAS-acting agents - Renin-angiotensin system

Product name: RAS-acting agents - Renin-angiotensin system
Active substance: benazepril, captopril, cilazapril, delapril, enalapril, fosinopril, imidapril, lisinopril, moexipril, perindopril, quinapril, ramipril, spirapril, trandolapril, zofenopril, candesartan, eprosartan, losartan, olmesartan, valsartan
Indication: The renin-angiotensin system (RAS) is a hormone system that regulates blood pressure and fluid balance. RAS-acting agents act by blocking different stages of the renin-angiotensin system, lowering blood pressure and their use in the treatment of hypertension and its complications (including acute myocardial infarction, congestive heart failure and chronic kidney disease) is recommended in many current clinical guidelines.
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/09/2014 Referral EMEA/H/A-31/1370 (2014)6371 of 04/09/2014
30/06/2017 Corrigendum (2017)4652 of 29/06/2017